Australia's largest stock trading and investment forum Australia's #1 stock forum

ALA

0.00%

16.5¢ arovella therapeutics limited

On the Bright Side, page-49

First 49 Last

Share
Profile

Follow
Beale

3,663 Posts.

656

25/06/16

17:16

Post #: 18123147
Share

Originally posted by Augment ↑

As a obviously naive long term holder of SUD I thought ( foolishly it seems) that a little honest and optimistic input into this
HC blog might boost morale with a bit of input.
But for some I am a liar, an IT claiming I know more than anyone else and basically full of s--t.
For those interested I get my information from research, comparisons and frequently asking many, many probing questions of the company management. Once I believe I have some knowledge I pass this on to other frustrated investors on this blog, to be useful and hopefully honest. But the information is my opinion and I believe logical thought.
There is no information I give that is not available to any of you who read and evaluate the announcements, watch webinar presentations, go to the AGM's and follow other similar Biotechs and their often long and painful histories. Some do spectacularly well and others fall by the wayside.
Logic plays an important part combined with announcements from the company, leading me to certain assumptions about prospective partners, etc.
For example it has been stated many times that the company is in late stage negotiations with 3 of the the top 5 major pharma.
Its not rocket science to work out that SUD-003 ( *word disallowed by google) would be a great match for Pfizer, as their Viagra patent lapses in 2020.( notwithstanding a deal they have done with TEVA to manufacture generics). Pfizer to me is the logical major pharma who may be looking at SUD-003 as a new and rapid acting form of Viagra. Why wouldn't they look at a cheap alternative? But of course they need the data to be comprehensive and prove that the absorption profile of a new formula is worth buying into! Thus the in vivo rabbit study taking place. If the results are good then perhaps Pfizer might buy that formula from SUDA? Thats my logical guess and not from any other information base.
Again ArtiMIST is moving , as can be seen by the announcements. Novartis are a major pharma who are selling Artemether drugs for subSaharan African malaria, and would be a very good fit to buy into ArtiMist. To me thats logical??
I suggest anyone who is able to speak to NW or SC should go to the office and ask as many questions as you want, as a SH,which is your right. It may even be worth catching a plane if able as this is better than a phone call.
The management can only give you an indication of whats happening, but with enough questions you may get a broader understanding of where things are at in negotiations.
All this seems more effective than repeating the "same old "on HC and accusing others of various things.

Thats me on HC for the time being. And yes I hope to buy a small parcel of SUD shares next week as I believe we're onto a frustrating, but 'good thing.'

Expand

Don't go missing just because of some of the fwits that live on here aug. I like your posts. There's only one reason none of them go away either. One thing I must say.....could be wrong but I've got Merck all over artimist! Not novartis!! Happy days coming !!

Last edited by Beale: 25/06/16

SUD Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

ASX Market Open: ASX200 to rise for Friday session | July 26

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Nine's staff strike as Paris Olympic coverage begins

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

There are more pages in this discussion • 9 more messages in this thread...

First 49 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 16.5¢		Change 0.000(0.00%)		Mkt cap ! $173.5M

Open	High	Low	Value	Volume
16.5¢	17.0¢	16.5¢	$114.3K	685.4K

Buyers (Bids)

No.	Vol.	Price($)
4	303820	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	197482	3

View Market Depth

No.	Vol.	Price($)
3	293820	0.165
14	568393	0.160
7	295419	0.155
6	446665	0.150
4	176474	0.145

Price($)	Vol.	No.
0.170	197482	3
0.175	253660	5
0.180	601641	6
0.185	1380870	13
0.190	292870	7

Last trade - 16.10pm 26/07/2024 (20 minute delay)

ALA (ASX) Chart

On the Bright Side, page-49

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

ASX Market Open: ASX200 to rise for Friday session | July 26

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Nine's staff strike as Paris Olympic coverage begins

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

On the Bright Side, page-49

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

ASX Market Open: ASX200 to rise for Friday session | July 26

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Nine's staff strike as Paris Olympic coverage begins

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News